Use of sigma receptor antagonists to enhance the effects of anti

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3144

Patent

active

052310990

ABSTRACT:
The invention relates to a method of treating psychosis in a mammal which comprises administering to the mammal an effective amount of a dopamine receptor antagonist antipsychotic and a sigma receptor antagonist having greater affinity for sigma receptors than for dopamine receptors, in an amount effective to selectively enhance the antipsychotic effects of the dopamine receptor antagonist relative to the adverse side effects of the dopamine receptor antagonist.

REFERENCES:
patent: 4232037 (1980-11-01), Florvall et al.
patent: 4400383 (1983-08-01), Davidson et al.
patent: 4588728 (1986-05-01), Ferris
Ferris et al., J. Pharm. Pharmacol. 1982, 34:388.
Ferris et al., Life Sciences, 1986, 38:2329.
Ogren et al., Eur. J. Pharm. 1984, 102:439.
Snyder and Largent, J. Neuropsyc. 1989, 1:7.
Taylor and Dekleva, Drug Dev. Res. 1987, 112:65.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Use of sigma receptor antagonists to enhance the effects of anti does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of sigma receptor antagonists to enhance the effects of anti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of sigma receptor antagonists to enhance the effects of anti will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2342444

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.